Trevi Therapeutics
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
-15.93-10.72-10.23-59.11
Price/Sales ratio
N/A160.5515.491.67
Earnings per Share (EPS)
$-0.46$-0.68$-0.71$-0.12

Historical Multiples (2016 – 2023)

2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-11.48-5.50-3.44-1.68-1.33-0.52-4.27-4.56-0.76-1.68
Price/Sales ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Price/Book Value ratio
-7.314.784.080.801.601.041.151.600.311.60
Price/Cash Flow ratio
-11.37-8.86-3.86-1.90-1.50-0.61-4.42-4.18-0.81-1.90
Price/Free Cash Flow ratio
-11.37-8.85-3.83-1.90-1.50-0.61-4.39-4.16-0.81-1.90
Price/Earnings Growth ratio
N/A-0.05-0.050.550.070.020.060.12-0.290.07
Dividend Yield
N/AN/AN/A5.08%N/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Pretax Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Net Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Effective Tax Rate
0.07%0.20%0.59%0.06%0.05%0.06%0.12%0.11%-0.06%0.05%
Return on Assets
-131.84%-57.85%-100.27%-43.41%-69.50%-88.21%-23.69%-32.51%-36.20%-43.41%
Return On Equity
63.68%-87.02%-118.70%-47.75%-120.07%-198.77%-27.12%-35.21%-61.77%-61.77%
Return on Capital Employed
71.97%-54.53%-103.34%-48.62%-78.14%-126.11%-27.28%-40.58%-40.82%-48.62%
Liquidity Ratios
Current Ratio
N/AN/AN/A11.458.32N/AN/AN/A9.158.32
Quick Ratio
0.413.106.4911.148.162.989.1515.038.998.99
Cash ratio
0.403.096.4111.028.102.890.935.560.938.10
Days of Sales Outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Inventory outstanding
N/AN/A22.15K15.01K6.95KN/AN/AN/AN/A6.95K
Operating Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Payables Outstanding
40.60KN/A9.56K14.96K15.65K20.79K24.25K5.36KN/A15.65K
Cash Conversion Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Debt Ratios
Debt Ratio
2.620.230.050.000.290.370.070.000.120.00
Debt Equity Ratio
-1.270.350.060.000.510.840.080.000.140.00
Long-term Debt to Capitalization
-0.41N/A0.05N/A0.330.330.01N/A0.000.33
Total Debt to Capitalization
4.700.260.050.000.340.450.070.000.000.34
Interest Coverage Ratio
N/AN/AN/AN/A-71.24N/AN/AN/A-27.02-71.24
Cash Flow to Debt Ratio
-0.50-1.50-16.68-233.26-2.06-1.99-3.07-103.62-1.53K-2.06
Company Equity Multiplier
-0.481.501.181.101.722.251.141.081.141.10
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Free Cash Flow / Operating Cash Flow Ratio
11.001.001.001.0011.001.001.001.00
Cash Flow Coverage Ratio
-0.50-1.50-16.68-233.26-2.06-1.99-3.07-103.62-1.53K-2.06
Short Term Coverage Ratio
-0.65-1.50N/A-233.26-256.63-4.96-4.02-103.62-1.65K-256.63
Dividend Payout Ratio
N/AN/AN/A-8.59%N/AN/AN/AN/AN/A-8.59%